Milestone Scientific Inc. (NYSE:MLSS) has announced the purchase of its CompuFlo Epidural and CathCheck Verification System disposables by two additional leading hospitals.
The company noted that the new orders will help expand its geographic footprint.
“These orders from well-recognized hospitals illustrate our continued traction in the market,” said Milestone Scientific CEO Arjan Haverhals in a statement.
“Importantly, both of these hospitals belong to large healthcare systems. One of these new hospitals represents an expansion to an additional location within its existing healthcare system, which is important validation of our technology," he added.
READ: Milestone Scientific inks deal with Andau Medical to distribute STA Single Tooth Anesthesia System in the US and Canada
Haverhals said the company’s instruments and disposables provide a level of safety and efficiency not currently available using conventional syringes.
“We have a growing pipeline of healthcare institutions across the country, and remain committed to our goal of establishing the CompuFlo Epidural instrument as the new standard of care in epidural anesthesia,” he said.
Milestone Scientific said the clinical and safety benefits of the CompuFlo Epidural and CathCheck Verification System are backed by numerous published clinical studies demonstrating reductions in epidural punctures and complication rates, and can contribute to time savings on the part of anesthesiologists.
“The momentum we’re gaining in the marketplace is a direct reflection of the growing clinical evidence supporting routine use of the CompuFlo Epidural and CathCheck Verification System in clinical practice,” said Dr. Mark Hochman, the company’s director of clinical affairs.
Milestone Scientific noted that a recent study has shown that the CompuFlo Epidural instrument has the potential to significantly reduce costs associated with morbidity, providing a direct economic benefit to healthcare institutions.
Similarly, the CathCheck Verification System has the potential to transform the monitoring of catheter placement by confirming the presence or absence of a pulsatile waveform which correlates to the correct placement of a catheter. This can be accomplished within two minutes, versus 20 to 40 minutes using conventional methods.
Contact the author: patrick@proactiveinvestors.com
Follow him on Twitter @PatrickMGraham